|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
US4501729A
(en)
|
1982-12-13 |
1985-02-26 |
Research Corporation |
Aerosolized amiloride treatment of retained pulmonary secretions
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5227160A
(en)
|
1988-07-15 |
1993-07-13 |
The Biomembrane Institute |
Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US6045786A
(en)
|
1989-02-01 |
2000-04-04 |
Johns Hopkins University |
Topical application of antibodies for prophylaxis against sexually transmitted diseases and pregnancy
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
EP1400536A1
(en)
*
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
US7211255B2
(en)
|
1996-01-29 |
2007-05-01 |
United States Of America The U.S. Environmental Protection Agency |
Contraceptives based on SP22 and SP22 antibodies
|
|
DK1071700T3
(da)
|
1998-04-20 |
2010-06-07 |
Glycart Biotechnology Ag |
Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
|
|
US7125550B2
(en)
|
2000-01-19 |
2006-10-24 |
University Of Virginia Patent Foundation |
Human sperm specific lysozyme-like proteins
|
|
EP1255831A2
(en)
|
2000-01-19 |
2002-11-13 |
The University Of Virginia Patent Foundation |
Sperm specific proteins
|
|
JP2003531588A
(ja)
*
|
2000-04-11 |
2003-10-28 |
ジェネンテック・インコーポレーテッド |
多価抗体とその用途
|
|
US6818216B2
(en)
*
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
JP2004535794A
(ja)
|
2001-05-03 |
2004-12-02 |
チルドレンズ・メディカル・センター・コーポレイション |
精子特異的カチオンチャネルおよびその使用
|
|
NZ571596A
(en)
|
2001-08-03 |
2010-11-26 |
Glycart Biotechnology Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
|
EP1448589A4
(en)
|
2001-10-22 |
2005-03-30 |
Childrens Medical Center |
THE SPERM SPECIFIC CATION CHANNEL CATSPER2 AND USES THEREOF
|
|
WO2004015067A2
(en)
|
2002-08-07 |
2004-02-19 |
Children's Medical Center Corporation |
Sperm-specific cation channel, catsper-3, and uses therefor
|
|
WO2004015066A2
(en)
|
2002-08-07 |
2004-02-19 |
Children's Medical Center Corporation |
Sperm-specific cation channel, catsper-4, and uses therefor
|
|
EP2248892B1
(en)
|
2003-01-22 |
2015-04-22 |
Roche Glycart AG |
Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function
|
|
WO2006050166A2
(en)
|
2004-10-29 |
2006-05-11 |
Medimmune, Inc. |
Methods of preventing and treating rsv infections and related conditions
|
|
US20090030187A1
(en)
*
|
2005-03-14 |
2009-01-29 |
Tous Guillermo I |
Macromolecules comprising a thioether cross-link
|
|
US20120237442A1
(en)
|
2005-04-06 |
2012-09-20 |
Ibc Pharmaceuticals, Inc. |
Design and Construction of Novel Multivalent Antibodies
|
|
US7846434B2
(en)
|
2006-10-24 |
2010-12-07 |
Trubion Pharmaceuticals, Inc. |
Materials and methods for improved immunoglycoproteins
|
|
US20110008329A1
(en)
|
2007-06-26 |
2011-01-13 |
Medlmmune, Llc |
Methods of Treating RSV Infections And Related Conditions
|
|
KR20110084196A
(ko)
|
2008-09-26 |
2011-07-21 |
유레카 쎄라퓨틱스, 인코포레이티드 |
다양한 글리코실화 패턴을 가진 세포계 및 단백질
|
|
CA2822288A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Medimmune, Llc |
Anti-c5/c5a/c5adesr antibodies and fragments
|
|
WO2012158818A2
(en)
*
|
2011-05-16 |
2012-11-22 |
Fabion Pharmaceuticals, Inc. |
Multi-specific fab fusion proteins and methods of use
|
|
WO2014070786A1
(en)
|
2012-10-29 |
2014-05-08 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for inhibiting pathogen infection
|
|
WO2014120975A1
(en)
|
2013-02-01 |
2014-08-07 |
California Institute Of Technology |
Antibody-mediated immunocontraception
|
|
TWI659968B
(zh)
*
|
2013-03-14 |
2019-05-21 |
再生元醫藥公司 |
針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法
|
|
JP6699551B2
(ja)
|
2014-07-15 |
2020-05-27 |
アステラス製薬株式会社 |
新規抗ヒトＴｉｅ２抗体
|
|
WO2018027204A1
(en)
*
|
2016-08-05 |
2018-02-08 |
Genentech, Inc. |
Multivalent and multiepitopic anitibodies having agonistic activity and methods of use
|
|
WO2018064603A1
(en)
*
|
2016-09-30 |
2018-04-05 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for crosslinking fc receptors
|